Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
What is Genetic Engineering?00:49

What is Genetic Engineering?

73.9K
Overview
73.9K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

935
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
935
Ethics and Bioethics01:22

Ethics and Bioethics

1.3K
Ethics is a philosophical study of moral actions. Ethics attempts to determine what is valuable for individuals and society. It examines the rational justification of moral judgments and analyzes what is morally just, fair, and right. Bioethics is a sub-discipline of applied ethics that analyzes the philosophical, social, and legal issues in life sciences and medicine. Ethical theories serve as a foundation for decision-making and represent the viewpoints from which people seek direction. They...
1.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025
Same author

Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UK.

European journal of medical genetics·2025
Same author

From roadmap to a sustainable end-to-end individualized therapy pathway.

Therapeutic advances in rare disease·2025
Same author

Lived Experience of Patients and Caregivers in Rare Genetic Neurological Gene Therapy Clinical Trials in Children.

Pediatric neurology·2024
Same author

The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap.

Nature reviews. Drug discovery·2024
Same author

Clinician Perspectives of Gene Therapy as a Treatment Option for Duchenne Muscular Dystrophy.

Journal of neuromuscular diseases·2024
Same journal

Common Principles Underlie Mitochondrial DNA Heteroplasmy Dynamics in the Germline and Soma.

Annual review of genomics and human genetics·2026
Same journal

Human Sex Chromosome Biology in the Genomic Era.

Annual review of genomics and human genetics·2026
Same journal

Beyond TADs and Compartments: Mesoscale Chromatin Folding and Its Dynamics in Transcriptional Regulation.

Annual review of genomics and human genetics·2026
Same journal

Experimental and Computational Approaches to Identify Noncoding Pathogenic Variation in Rare Disease.

Annual review of genomics and human genetics·2026
Same journal

How Studying Rare Disease Leads to Mechanistic Insights and Therapeutic Development: Lessons from Nonmammalian Models.

Annual review of genomics and human genetics·2026
Same journal

Synthetic Regulatory Genomics.

Annual review of genomics and human genetics·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.9K

Somatic Gene Therapy: Ethics and Access.

Alison Bateman-House1

  • 1Division of Medical Ethics, NYU Grossman School of Medicine, New York, NY, USA;

Annual Review of Genomics and Human Genetics
|August 27, 2024
PubMed
Summary
This summary is machine-generated.

Somatic gene therapy offers disease modification but faces safety and access challenges. Early decisions in gene therapy development significantly impact future patient access to treatments.

Keywords:
access to novel technologiesequityethicsgene editinggenetic therapy

More Related Videos

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

12.6K
Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.4K

Related Experiment Videos

Last Updated: Jun 15, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.9K
In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

12.6K
Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications
03:52

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

2.4K

Area of Science:

  • Biotechnology
  • Genetics
  • Medical Ethics

Background:

  • Somatic gene therapy is emerging as a therapeutic approach with the potential to modify diseases.
  • Despite progress, significant scientific uncertainties regarding safety and long-term efficacy persist.
  • Ethical considerations, particularly concerning patient access to novel gene therapies, are paramount.

Purpose of the Study:

  • To explore the multifaceted nature of access issues in gene therapy.
  • To examine how access challenges arise early in the development pipeline, prior to commercialization.
  • To analyze the implications of upstream developmental decisions on eventual patient access.

Main Methods:

  • The study involves a critical review of current gene therapy development practices.
  • Analysis of ethical frameworks related to healthcare interventions and resource allocation.
  • Examination of how specific choices in research and development influence accessibility.

Main Results:

  • Access issues in gene therapy are present long before products reach the market.
  • Decisions regarding therapeutic targets, vector choice, and clinical trial locations critically shape accessibility.
  • Upstream choices have profound implications for both the development and commercial stages of gene therapy.

Conclusions:

  • Addressing gene therapy access requires consideration of factors beyond product cost.
  • Ethical and practical challenges in gene therapy development must be proactively managed to ensure equitable access.
  • A holistic approach is needed to navigate the complexities of gene therapy accessibility from inception to market.